Stephens Investment Management Group LLC lowered its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 3.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 685,834 shares of the medical equipment provider’s stock after selling 22,832 shares during the period. Stephens Investment Management Group LLC owned approximately 1.40% of BioLife Solutions worth $26,645,000 as of its most recent SEC filing.
Other institutional investors have also modified their holdings of the company. First Trust Capital Management L.P. acquired a new stake in BioLife Solutions during the 3rd quarter valued at approximately $55,365,000. Bank of America Corp DE raised its position in shares of BioLife Solutions by 73.4% in the 1st quarter. Bank of America Corp DE now owns 904,103 shares of the medical equipment provider’s stock valued at $17,250,000 after purchasing an additional 382,776 shares in the last quarter. Alberta Investment Management Corp acquired a new position in shares of BioLife Solutions in the 3rd quarter valued at approximately $13,928,000. Granahan Investment Management LLC raised its position in shares of BioLife Solutions by 49.7% in the 1st quarter. Granahan Investment Management LLC now owns 722,057 shares of the medical equipment provider’s stock valued at $13,777,000 after purchasing an additional 239,701 shares in the last quarter. Finally, Ranger Investment Management L.P. purchased a new position in shares of BioLife Solutions during the 2nd quarter valued at approximately $6,736,000. Institutional investors and hedge funds own 93.24% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on the stock. Zacks Research downgraded shares of BioLife Solutions from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 21st. Jefferies Financial Group lowered shares of BioLife Solutions from a “buy” rating to a “hold” rating and lifted their price target for the stock from $30.00 to $31.00 in a research note on Thursday, July 23rd. Benchmark cut shares of BioLife Solutions from a “buy” rating to a “hold” rating in a report on Monday, August 10th. Stephens downgraded shares of BioLife Solutions from an “overweight” rating to an “equal weight” rating and dropped their target price for the stock from $32.00 to $31.00 in a research report on Monday, July 27th. Finally, Wall Street Zen lowered shares of BioLife Solutions from a “buy” rating to a “hold” rating in a research note on Saturday, July 25th. One investment analyst has rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $31.38.
Check Out Our Latest Stock Report on BLFS
BioLife Solutions Stock Performance
NASDAQ:BLFS opened at $38.61 on Friday. BioLife Solutions, Inc. has a 52 week low of $17.86 and a 52 week high of $39.76. The stock has a 50 day moving average of $38.21 and a 200-day moving average of $28.96. The firm has a market capitalization of $1.89 billion, a PE ratio of 33.28 and a beta of 1.82.
BioLife Solutions Profile
BioLife Solutions, Inc. develops and supplies products and services used in the development and commercial production of cell and gene therapies and other biologic medicines. Its offerings support the handling, preservation, storage and distribution of sensitive biological materials. The company’s products include CryoStor and HypoThermosol preservation media, as well as CellSeal bags designed for cryogenic storage. BioLife also provides temperature-controlled storage and repository services for biological materials through its SciSafe business.
Read More
- Five stocks we like better than BioLife Solutions
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding BLFS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report).
Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
